Clinical trial Recruiting at 1 site Observational Ages 3 to 85

Inflation-based non-invasive blood pressure test compared with standard cuff method

Official title: Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study

Run by Philips Clinical & Medical Affairs Global · NCT07901608 · Data updated 2026-11-12

This study tests whether the Philips iNIBP device gives BP readings that match the usual auscultatory cuff method in people aged 3 to 85.

Quick facts

Study typeObservational
Ages3 Years to 85 Years
SexAll
Enrollment85 (estimated)
SponsorPhilips Clinical & Medical Affairs Global
Industry-sponsored
Locations1 site (Louisville, Colorado)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 28, 2026
Trial IDNCT07901608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are participants aged 3–85 with upper-arm circumference 14–43 cm who can consent or assent and understand English for study procedures.

Probably not a fit

Participants with arm deviations or conditions preventing proper device application may not experience benefit from the iNIBP measurements.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares inflationary-based non-invasive blood pressure measurements from the Philips iNIBP system to the reference auscultatory method. Using a same-arm, sequential measurement with two independent observers, the study evaluates bias and variability in systolic, diastolic, and mean arterial pressure. The goal is to determine equivalence of the two approaches for accurate BP assessment across a wide age range. Data will inform whether iNIBP can provide reliable blood pressure readings in routine clinical or research settings.

Why it matters

Potential benefit: If successful, the iNIBP system could offer accurate BP readings without auscultation, potentially simplifying measurement workflows.

How similar studies have gone: Past studies outside this protocol have shown mixed results; this study contributes targeted validation for the Philips iNIBP approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be 3 to 85 years of age.
* Participants, parents or legal guardians of participants must be able to provide informed consent, parental permission, and/or assent form.
* Participants that are between 7 and 17 (inclusive) years of age must provide assent to participate in the study.
* Participants, parents or legal guardians of participants must be able to read or write in English and participants that are between the age of 7-17 must be able to understand English to provide assent.
* Participant must be willing and able to comply with study procedures and duration.
* Participants must have an upper arm circumference in the range of 14-43 centimeters.

Exclusion Criteria:

* Participant, parent or legal guardian of participant is unwilling to provide informed consent, parental permission, and/or assent.
* Participants with deformities or abnormalities that may prevent proper application of the device under test.
* Participants with an upper arm circumference less than 14 cm or greater than 43 cm.
* Female participants who are pregnant.
* Female participants who are trying to get pregnant with confirmation of positive urine pregnancy test.
* Participants with known heart arrhythmias.
* Participants with peripheral vascular disease.
* Participants with clotting disorders.

  * History of bleeding disorders or personal history of prolonged bleeding from injury.
  * History of blood clots.
  * Hemophilia.
* Participants that cannot tolerate sitting for up to 1-2 hours.
* Participant with a blood pressure or other demographics that have already been filled.
* Other known health conditions that will prevent safe participation in the study upon disclosure in screening form or verbally.
* Participant is evaluated by the investigator or clinician and found to be medically unsuitable for participation in this study.
* Participants where the Korotkoff sounds (fifth phase (K5)) for determining DBP is not audible.

Where it's running

  • Element Materials Technology
    Louisville, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.